Clinical Results with Nonthoracotomy ICD Systems

ROBERT G. HAUSER, DOUGLAS T. KURSCHINSKI, KEVIN McVEIGH, ANDRA THOMAS, MORTON M. MOWER

Research output: Contribution to journalArticlepeer-review

Abstract

The results of two separate US Food and Drug Administration clinical trials that involved endocardial and epicardial leads were compared with regard to patient demographics, detection and conversion characteristics, and subsequent clinical course including long‐term survival experience. The patient groups, although not strictly contemporaneous, were sufficiently similar to allow meaningful comparisons. There were no significant differences in detection of induced arrhythmias and ability to convert them. The surgical mortality, infection rate, and incidence of other morbid complications were lower in patients who had received endocardial leads; however, the differences did not reach statistical significance. Survivals through 1 year of follow‐up were uniformly high. These results suggest that the performance of the endocardial lead system is comparable to existing epicardial leads in similar patient populations.

Original languageEnglish (US)
Pages (from-to)141-148
Number of pages8
JournalPacing and Clinical Electrophysiology
Volume16
Issue number1
DOIs
StatePublished - Jan 1993
Externally publishedYes

Keywords

  • endocardial lead systems
  • epicardial leads
  • sudden death survival
  • transvenous leads

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Clinical Results with Nonthoracotomy ICD Systems'. Together they form a unique fingerprint.

Cite this